Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Laws

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Nature Aging|April 28, 2023
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's diseaseYuanbing Jiang, Xiaopu Zhou, Hiu Yi Wong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Translational Psychiatry|July 25, 2022
Polygenic resilience scores capture protective genetic effects for Alzheimer's diseaseJiahui Hou, Jonathan L Hess, Nicola Armstrong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Nature Aging|April 28, 2023
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's diseaseYuanbing Jiang, Xiaopu Zhou, Hiu Yi Wong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Translational Psychiatry|July 25, 2022
Polygenic resilience scores capture protective genetic effects for Alzheimer's diseaseJiahui Hou, Jonathan L Hess, Nicola Armstrong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
Pageof 19